Charles Winter
Chief Technical OfficeratJanux Therapeutics· In proxies 2022–2023
Pay in FY2023+4% from the year before · Janux Therapeutics stock -18.5% the same year
Charles Winter was paid $1.6M in FY2023 (Dec), up 4%. Janux Therapeutics stock fell 18.5% that year.
Pay$100 in the stock at the end of FY21 → $54
Experience
- Janux TherapeuticsPublic company · 4 yr
- Chief Technical Officer2022 – Present · 4 yrStock in role -11%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?